We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rosetta Licenses the Rosetta Resolver System to the FGCZ
News

Rosetta Licenses the Rosetta Resolver System to the FGCZ

Rosetta Licenses the Rosetta Resolver System to the FGCZ
News

Rosetta Licenses the Rosetta Resolver System to the FGCZ

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Rosetta Licenses the Rosetta Resolver System to the FGCZ"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Rosetta Biosoftware has announced that the Functional Genomics Center of Zurich, Switzerland (FGCZ) licensed the Rosetta Resolver system.

The FGCZ will use the Resolver system to analyze and store cross-platform microarray data generated from the hundreds of regional functional genomic projects supported by the expert institution.

"Rosetta Biosoftware is pleased to provide the FGCZ with a flexible and integrated informatics solution that will guarantee consistency and quality for their gene expression research," said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware.

"The Resolver system provides advanced tools for raw and analytical gene expression data management."

"The cross-species and cross-platform analysis tools in the system will help the FGCZ advance their research in transcriptomics."

"We are pleased to add the Resolver system to our strong portfolio of analytical resources for conducting genome-wide, high-resolution gene expression analysis," said Dr. Ralph Schlapbach, managing director of the FGCZ.

"The central database and standardized statistical tools will enable all our users to efficiently analyze microarray data for differential expression."

Advertisement